Question explored with the scientific record
Did ferrets die in COVID trials
The retrieved studies do not report ferret deaths in COVID-19 trials.
The evidence block contains a 2023 study that used 12-month-old male ferrets to test intranasal vaccines [1]. The study measured virus titers, immune responses, and antibody levels. It does not mention any ferret deaths. The ferrets were euthanized at set timepoints (day 7 and day 14 post-challenge) for tissue collection [1]. That is a planned sacrifice, not a death from the infection or the vaccine.
A 2020 Nature review on animal models for COVID-19 describes ferrets as developing mild upper-respiratory infection with "mild clinical signs" [2]. It does not list death as a typical outcome in ferret studies. Another 2020 review notes ferrets are "permissive" to experimental infection but does not report mortality [4].
The 2020 review of SARS-CoV spike vaccines in animal models does mention that a modified vaccinia virus Ankara (MVA-S) vaccine in ferrets produced "strong ADE effects" (antibody-dependent enhancement) but does not say whether any ferrets died [3].
My call: the evidence retrieved here does not contain a single report of ferret deaths in COVID-19 trials. Ferrets are used as a mild-disease model, and planned euthanasia for tissue collection is standard. Confidence: high that the retrieved studies do not document ferret mortality.
Sources used 4
-
Enhanced mucosal immune responses and reduced viral load in the respiratory tract of ferrets to intranasal lipid nanoparticle-based SARS-CoV-2 proteins and mRNA vaccines
Intranasal liposome-encapsulated SARS-CoV-2 S-RBD and N protein vaccine with MSU adjuvant reduced infectious virus in the respiratory tract of aged ferrets and induced Th1/Th2 cytokine and IgG responses, while the mRNA vaccine reduced virus but mainly induced antibody responses.
DOI: 10.1186/s12951-023-01816-3 -
Animal models for COVID-19
This Nature Review summarizes the state of animal models for COVID-19, comparing mouse, hamster, ferret, and non-human primate models (plus other species) and discussing their readouts, limitations, and implications for preclinical vaccine and therapeutic testing, with recommend…
DOI: 10.1038/s41586-020-2787-6 -
Protective Immunity against SARS Subunit Vaccine Candidates Based on Spike Protein: Lessons for Coronavirus Vaccine Development
This narrative review of SARS-CoV spike-based vaccine candidates in animal models finds that subunit, DNA, and viral-vector vaccines can induce neutralizing antibodies and protective immunity, but safety concerns such as antibody-dependent enhancement and incomplete protection r…
DOI: 10.1155/2020/7201752 -
Evidence for SARS-CoV-2 Infection of Animal Hosts
This review summarizes evidence that SARS-CoV-2 originated from bats and/or pangolins, causes natural infections in cats, dogs, tigers, lions, and minks via human-to-animal transmission, and demonstrates permissive experimental infection in monkeys, hamsters, ferrets, cats, tree…
DOI: 10.3390/pathogens9070529